Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Cirrhosis
In brief
This study is being done to better understand how the study team can treat pain for people with cirrhosis and depression. Enrolled participants on this feasibility study will be randomized to Transcutaneous Electrical Acustimulation (TEA) or sham TEA.
Key facts
- Study ID
- NCT06932783
- Run by
- University of Michigan
- People needed
- 30
- Starts
- 2025-07-22
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-03-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of cirrhosis - must meet the criteria as outlined in the protocol
- Chronic pain (Patient self-reports ≥ 4 on the 0-10 scale for >50% of days within 3- months)
- Depression (in at least half of participants) - must meet the criteria as outlined in the protocol
- English speaking
- Willing to use a Transcutaneous Electrical Acustimulation device
You may not qualify if…
- Dementia and/or severe cognitive impairment
- Unable or unwilling to provide consent
- Expected to undergo liver transplant in next 24 weeks
- No email address
- Deemed unsuitable by the study investigator
Where it is running
- University of Michigan — Ann Arbor, Michigan, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.